Risk Management

Misleading 'Made in USA' Claims Lead to FTC fines

Misleading ‘Made in USA’ Claims Lead to FTC fines

Dive into the implications for honest business practices following the FTC’s record-breaking penalty as Williams-Sonoma is fined for misleading ‘Made in USA’ claims.

FTC Noncompete Ban: Compliance, Ethical Challenges, and Alternative Strategies

FTC Noncompete Ban: Compliance, Ethical Challenges, and Alternative Strategies

Learn more about the FTC noncompete ban, which is set to reshape the corporate landscape, demanding significant adjustments from employers and compliance officers alike.

With Corporate Transparency Act Compliance, Uncertainty Remains

With Corporate Transparency Act Compliance, Uncertainty Remains

Is your organization impacted by the Corporate Transparency Act? Learn more about steps toward compliance.

Global Economic Shifts, AI, and Climate Risks: Insights from RISKWORLD 2024

Global Economic Shifts, AI, and Climate Risks: Insights from RISKWORLD 2024

Gain insights from this year’s RISKWORLD conference where panelists discuss the effects of global economic shifts, AI, and climate risks on the insurance industry.

Opportunity and Risk in Commodity Trading

Opportunity and Risk in Commodity Trading

Explore how adeptly navigating risk in commodity trading unlocks opportunities for success in this ever-evolving landscape.

Compliance Risks in Healthcare Investments: Strategies for Private Equity Firms

Compliance Risks in Healthcare Investments: Strategies for Private Equity Firms

As private equity firms delve into the lucrative yet complex healthcare sector, mitigating compliance risks in healthcare investments is more important than ever.

Quarterly Insurance Rate Trends: Steady Upticks in the U.S., Varied Shifts Globally

Quarterly Insurance Rate Trends: Steady Upticks in the U.S., Varied Shifts Globally

Gain insights into quarterly insurance rate trends, the nuances of property, casualty, and financial lines, and how regional fluctuations shape the industry.

FDA Compliance to Ensure Transparency in Clinical Data Reporting

FDA Compliance to Ensure Transparency in Clinical Data Reporting

Learn how regulatory scrutiny on ClinicalTrials.gov submissions is reshaping FDA compliance practices.

How Risk Analysis Safeguards Organizations

How Risk Analysis Safeguards Organizations

Discover how risk analysis fortifies businesses, empowering them to navigate complex landscapes with confidence and foresight.

FDA Announces Regulation of Laboratory Developed Tests (LDTs) as Medical Devices

FDA Announces Regulation of Laboratory Developed Tests (LDTs) as Medical Devices

Learn more about a pivotal shift in the regulation of Laboratory Developed Tests, and the FDA’s recent announcement marking them as medical devices subject to stringent oversight.

Get our free daily newsletter

Subscribe for the latest news and business legal developments.

Scroll to Top